|
Name |
Sydowinin A
|
| Molecular Formula | C16H12O6 | |
| IUPAC Name* |
methyl 8-hydroxy-6-(hydroxymethyl)-9-oxoxanthene-1-carboxylate
|
|
| SMILES |
COC(=O)C1=C2C(=CC=C1)OC3=CC(=CC(=C3C2=O)O)CO
|
|
| InChI |
InChI=1S/C16H12O6/c1-21-16(20)9-3-2-4-11-13(9)15(19)14-10(18)5-8(7-17)6-12(14)22-11/h2-6,17-18H,7H2,1H3
|
|
| InChIKey |
UBYOEDLUKKPPPN-UHFFFAOYSA-N
|
|
| Synonyms |
SYDOWININ A; 58450-01-4; ZS4IVQ1908; CHEBI:68227; methyl 8-hydroxy-6-(hydroxymethyl)-9-oxoxanthene-1-carboxylate; Methyl 8-hydroxy-6-(hydroxymethyl)-9-oxo-xanthene-1-carboxylate; methyl 8-hydroxy-6-(hydroxymethyl)-9-oxo-9H-xanthene-1-carboxylate; 9H-Xanthene-1-carboxylic acid, 8-hydroxy-6-(hydroxymethyl)-9-oxo-, methyl ester; UNII-ZS4IVQ1908; MEGxm0_000150; CHEMBL1812028; ACon1_000704; DTXSID00635917; ZINC14455391; NCGC00169440-01; BRD-K19034484-001-01-6; Q27136720; NCGC00169440-02!methyl 8-hydroxy-6-(hydroxymethyl)-9-oxoxanthene-1-carboxylate
|
|
| CAS | 58450-01-4 | |
| PubChem CID | 23872092 | |
| ChEMBL ID | CHEMBL1812028 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 300.26 | ALogp: | 2.1 |
| HBD: | 2 | HBA: | 6 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 93.1 | Aromatic Rings: | 3 |
| Heavy Atoms: | 22 | QED Weighted: | 0.557 |
| Caco-2 Permeability: | -4.93 | MDCK Permeability: | 0.00001240 |
| Pgp-inhibitor: | 0.006 | Pgp-substrate: | 0.234 |
| Human Intestinal Absorption (HIA): | 0.034 | 20% Bioavailability (F20%): | 0.009 |
| 30% Bioavailability (F30%): | 0.965 |
| Blood-Brain-Barrier Penetration (BBB): | 0.108 | Plasma Protein Binding (PPB): | 86.65% |
| Volume Distribution (VD): | 0.944 | Fu: | 14.96% |
| CYP1A2-inhibitor: | 0.97 | CYP1A2-substrate: | 0.811 |
| CYP2C19-inhibitor: | 0.489 | CYP2C19-substrate: | 0.069 |
| CYP2C9-inhibitor: | 0.757 | CYP2C9-substrate: | 0.858 |
| CYP2D6-inhibitor: | 0.737 | CYP2D6-substrate: | 0.321 |
| CYP3A4-inhibitor: | 0.499 | CYP3A4-substrate: | 0.141 |
| Clearance (CL): | 2.968 | Half-life (T1/2): | 0.846 |
| hERG Blockers: | 0.016 | Human Hepatotoxicity (H-HT): | 0.059 |
| Drug-inuced Liver Injury (DILI): | 0.879 | AMES Toxicity: | 0.413 |
| Rat Oral Acute Toxicity: | 0.009 | Maximum Recommended Daily Dose: | 0.063 |
| Skin Sensitization: | 0.524 | Carcinogencity: | 0.028 |
| Eye Corrosion: | 0.006 | Eye Irritation: | 0.917 |
| Respiratory Toxicity: | 0.08 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002106 | ![]() |
0.776 | D0K8KX | ![]() |
0.344 | ||
| ENC002668 | ![]() |
0.722 | D04AIT | ![]() |
0.322 | ||
| ENC002690 | ![]() |
0.722 | D06GCK | ![]() |
0.313 | ||
| ENC004885 | ![]() |
0.671 | D0Z3DY | ![]() |
0.312 | ||
| ENC002283 | ![]() |
0.671 | D0G5UB | ![]() |
0.301 | ||
| ENC005347 | ![]() |
0.657 | D0G7IY | ![]() |
0.300 | ||
| ENC003785 | ![]() |
0.653 | D0U0OT | ![]() |
0.295 | ||
| ENC002135 | ![]() |
0.590 | D0QD1G | ![]() |
0.295 | ||
| ENC002284 | ![]() |
0.587 | D06NSS | ![]() |
0.289 | ||
| ENC004886 | ![]() |
0.587 | D0H2ZW | ![]() |
0.284 | ||